Related Experiment Video
Updated: May 16, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
The current status of robotic oncologic surgery
Hua-Yin Yu1, David F Friedlander, Sunil Patel
1Department of Urology, Kaiser Permanente Oakland Medical Center, Oakland, California, USA.
CA: a Cancer Journal for Clinicians
|November 20, 2012
Summary
Robotic surgery offers short-term benefits in cancer treatment, like reduced hospital stays. However, long-term outcomes and higher costs require further study to justify its widespread use.
Area of Science:
- Surgical Technology
- Oncology
- Minimally Invasive Procedures
Background:
- Robotic assistance is increasingly used in minimally invasive surgery across various medical specialties.
- Adoption of robotic technology in oncologic surgery has grown significantly.
Purpose of the Study:
- To review the published literature on the use of robotic technology for treating oncologic conditions.
- To assess the benefits, drawbacks, and current evidence regarding robotic surgery in oncology.
Main Methods:
- Conducted PubMed searches for articles published between 2000 and 2012.
- Used keywords such as "robotic surgery" and "oncology" or "cancer".
Main Results:
- Robotic surgery is most common in urologic oncology but also used in gynecologic, general, thoracic, and head and neck surgeries.
- Short-term benefits include shorter hospital stays and less blood loss, with comparable safety and oncologic outcomes to traditional methods.
- Long-term oncologic outcomes data are limited, and robotic surgeries incur higher costs.
Conclusions:
- Robotic technology is established in oncologic surgery with clear short-term advantages.
- Further comparative effectiveness studies with long-term data are needed to evaluate if robotic benefits outweigh increased costs.